Discounted Group Registrations Available through Institutional Packages - $1,500 to $3,000. This, of course, takes time and can create stress for pet owners. Uniquely, the TRUFORMA platform uses Bulk Acoustic Wave (BAW) technology, developed by Qorvo, to provide a non-optical and fluorescence-free detection system for use at the point-of-care. Its on the verge of launching its first product, a veterinary diagnostic kit for dogs and cats. Six months ago, 15 million shares would trade hands on a good day. The potentially revolutionary TRUFORMA diagnostic device is smaller than a desktop printer and is designed to provide highly sensitive, species-optimized initial assays for the diagnosis of thyroid disease in dogs and cats, and adrenal disease in dogs. Reader AdvisoryExcept for statements of historical fact, this news release contains certain "forward-looking information" or forward-looking statements (collectively, forward-looking information) within the meaning of applicable securities law. For more information, visit www.ZOMEDICA.com. Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. When youre investing in penny stocks, the axiom that pigs get fat, hogs get slaughtered is apt advice. I am most excited to use endogenous ACTH in my work as a veterinary internist to help owners make difficult decisions about medical care, including the decision to pursue complex adrenal surgery.. Despite the drama over the past three weeks, ZOM shares are still up more than 2,500% compared to the value in late October. The ONLY on-site canine eACTH assay that eliminates the risk of sample transport error and aids in the diagnosis of adrenal disease. Real Madrid are the defending champions, having won their 35th title the previous season.. With the 2022 FIFA World Cup having commenced on 20 November, there was a mid . Copyright Assuming successful completion of verification, the goal is to complete . The bottom line on Zomedica like so many under-the-radar companies of late is that it caught the attention of the Reddit/Robinhood investing crowd. This website uses cookies to improve your experience while you navigate through the website. The dynamic range of the canine TRUFORMA cortisol assay is 0.35-24.0 g/dL compared to the Siemens IMMULITE Cortisol assay dynamic range of 1-50 g/dL. Having an accurate and reliable, patient-side, cortisol assay will allow veterinarians to manage canine adrenal diseases more effectively and efficiently, and could save lives." I would like to express my deepest gratitude to the many people at Zomedica who dedicated the past two years of their lives to achieving this critical milestone, commented Robert Cohen, Zomedicas Chief Executive Officer. We are, of course, approaching our planned March 30 th commercial launch of TRUFORMA, our point-of-care diagnostic platform. Fill out the form below and well send along some additional materials to help you decide if TRUFORMA is a good fit for your clinic. Investor Relations Contact: PCG Advisory Kirin Smith, Presidentksmith@pcgadvisory.com+1 646.823.8656, https://www.linkedin.com/company/zomedica. A sought-after lecturer and instructor, Dr. Berg has published numerous articles in peer-reviewed journals, including those of the American VeterinaryMedical Association (AVMA), the American College of Veterinary Internal Medicine (ACVIM), and the American Animal Hospital Association (AAHA). The information contained on this may be Paid Advertising for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the Securities Act). And at a time when pet ownership in the U.S. has never been higher, thanks to the pandemic. contact@marketbeat.com These cookies do not store any personal information. Included in their research and development activities, Zomedica screened 25 monoclonal antibodies pairs to determine an antibody pair with optimum performance for canine and feline testing. It is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. The pandemic-fueled pet boom is only going to raise that. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. The ability to reliably and accurately measure cortisol on-site in our emergency service at Guardian Veterinary Specialists has the potential to save lives. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Part of the reason for that number is that the company spent about $2 million less on research and development and cut general and administrative expenses by about $ 1 million. Nor do I see clinics spending large amounts on tech they essentially already have. ANN ARBOR, Mich., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp.(NYSE American: ZOM) (Zomedica or the Company), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA point-of-care diagnostic platform on March 30, 2021. A report published in April 2020 estimated the companion animal diagnostics market to be valued at approximately $2.0 billion in 2019. Necessary cookies are absolutely essential for the website to function properly. With the instrument and three of five of the initial assays available for sale, the decision was made to initiate the commercial launch of TRUFORMA ahead of the previously disclosed March. March 16, 2021 06:00 ET However, we can look at their respective overall companion animal groups (which include the diagnostics business) to get a sense of how entrenched they are. It is Zomedicas mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. Its hard to come by the exact figures of how much Zomedicas competitors make in the companion animal diagnostics market. The company has a first mover advantage in an underserved market. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. All rights reserved. Regardless- Truforma is the real deal , FDA approved & ready to launch. The Launch of Truforma Should Send Zomedica to An All-Time High Fri., March 12, 2021 | Chris Markoch Zomedica (NYSEAMERICAN:ZOM) is a pre-revenue company that is about to bring its first product to market. In January, Carole Baskin of Tiger King fame was paid $299 by a fan to mention Zomedia on Cameo. From a market perspective for TRUFORMA, a 2019-2020 American Pet Products Association National Pet Owners Survey indicated that 42.7 million U.S. households own at least one cat. PCG may be compensated by respective clients for publicizing information relating to its clients securities. The negative 5 cents per share was also a significant improvement over the negative 19 cents per share reported in 2019. You may find his writing a little different than other stock articles youve read. It is a credit to both our employees and to the stellar team with whom we have worked at our development partner, Qorvo Biotechnologies LLC, that we have created a unique and valuable diagnostic tool, and have delivered it to the veterinary market slightly ahead of our previously announced schedule., James Klein, president of Qorvo Biotechnologies said, At Qorvo, we are leveraging the power of Bulk Acoustic Wave (BAW) radio frequency (RF) technology to innovate numerous products such as Wi-Fi routers, mobile phones, 5G cellular infrastructure and now veterinary diagnostics. With any penny stock a range of outcomes is possible. In his latest feat, Louis discovered the Master Key to profiting fromthe biggest tech revolution of this (or any) generation. Potentially competitive technology: Zomedica has been pitching Truforma as a tool that provides improved test accuracy in a shorter time. This is a momentous day for Zomedica, our shareholders, the veterinarians we serve, and the companion animals in their care. 5 Hypergrowth Stocks With 10X Potential in 2023, 7 Sorry Pharma Stocks to Sell in April Before Its Too Late, Louis Navellier and the InvestorPlace Research Staff, 5 Penny Stocks With Explosive 5X Potential, Another Rare Bullish Indicator Flashed Last Week. Zomedica pointed to dynamic range as being another critical factor in favor of its TRUFORMA device. Should you invest $1,000 in Zomedica right now? Investor Relations Contact: PCG Advisory GroupKirin Smith, COOksmith@pcgadvisory.com+1 646.863.6519. 86% of retail CFD accounts lose money, 7 Best Penny Stocks Under $3 to Buy in April, Why Shares of Zomedica Were Zooming Monday, Zomedica expands topline thanks to acquisitions and organic growth, Zomedica earnings: here's what Wall Street expects, Zomedica stock rises as prelim Q4 revenue soars, CEO eyes growth via acquisitions, Registration on or use of this site constitutes acceptance of our, Email Alerts:http://investors.zomedica.com, LinkedIn:https://www.linkedin.com/company/zomedica. He received his DVM degree from Texas A&M University and went on to complete his internship and residency training in veterinary neurology and internal medicine at The AnimalMedical Center in New York City, receiving board certification in neurology in 2000 and in internal medicine in 2002. That has been the ZOM stock story in 2021. Create your Watchlist to save your favorite quotes on Nasdaq.com. Enter Truforma, a point-of-care test that veterinarians can use to run such tests in their office. I very much look forward to being able to report our first sale following launch.. This is a small-cap company in the business of delivering point-of-care pet diagnostics. PCG is an integrated investor relations, communications and strategic advisory firm. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. These cookies will be stored in your browser only with your consent. Get Out Now. Dynamic range is the functional range of a test over which the concentrations of an analyte can be measured with acceptable accuracy and precision. We cannot guarantee future results, performance or achievements. Chris has been writing for MarketBeat since 2018. Due date calculations for Project Center items do not take into account the time an item was created, but are based on full days. Canine-Optimized Cortisol assay that delivers reference lab accuracy with point-of-care convenience. This webinar will introduce attendees to the use of biomarkers in critical illness; more specifically the use of the endocrine parameters; cortisol and thyroxine in canine critical illness. BAW technology, also used in cell phones and in the worlds most advanced radar and communications systems, is an extremely reliable and precise technology. Now available for purchase are TSH, total T4, and cortisol assays. Zomedica noted that if the same samples are tested on two different types of machines and achieve exactly the same results, the correlation would be R=1. Project Timeline Overview. Please visit our. 1125 N. Charles St, Baltimore, MD 21201. Zomedica has announced that they will begin commercialization of TRUFORMA on March 30, 2021, and will continue the development of ZM-020 and ZM-017 diagnostic platforms (to diagnose. These cookies will be stored in your browser only with your consent. All rights reserved. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on and Zomedica wasn't on the list. 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, Proterra Inc., A Penny Stock To Put On The Watchlist, Buffett Reduces Taiwan Semiconductor Stake After This Happened, Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI, Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, Why Restaurant Stocks are the Stocks to Buy Right Now, View 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, View Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher, View Proterra Inc., A Penny Stock To Put On The Watchlist, View 3 Healthcare Stocks Insiders Are Buying, View Buffett Reduces Taiwan Semiconductor Stake After This Happened, View Nio Inc - (NYSE:NIO) Shares Sold by National Bank of Canada FI. Big Market In Companion Animal Treatments. Verification data comparing the canine TRUFORMA cortisol assay to the Siemens IMMULITE Cortisol reference lab assay showed high correlation (R=0.97). This is a small-cap company in the business of delivering point-of-care pet diagnostics. Total-T4 Assay with enhanced dynamic range. IDEXX is trading well over $500 a piece. ANN ARBOR, Mich., May 20, 2020 (GLOBE NEWSWIRE) -- Zomedica (NYSE American: ZOM), a veterinary diagnostic company, announced today that it has completed the final verification of three additional. Heres a look at the pros and cons of buying ZOM stock. Combined with the previously verified canine total tT4 assay, the total represents the completion of the first two assays for both canine and feline of the total of five assays initially planned for use with the TRUFORMA platform. At this stage, tests are available for thyroid and adrenal issues, but more are coming, including tests for gastrointestinal conditions currently the most common insurance claim for dog owners. Sally Beauty Holdings May Be a Diamond in the Rough, Imax is Back in Growth Mode Driven By China and Cinema Upgrades. However, this is a company that has struggled mightily to get here. An attempted reverse stock split was rejected by shareholders. The most recent verification of its canine and feline TSH assays is noteworthy because Zomedica says they are unaware of a validated species-optimized TSH assay currently available for felines at either the point-of-care or at a reference lab. The company will release Truforma along with three assays in a limited geographic area as of March 30. The fact that some of our assays under development not only are believed to be the first ever developed for use at the point-of-care, but also the first ever available in veterinary medicine, is expected to be an exciting contribution to the health and treatment of our pets.". Youll have to wait and see. Flexible use cases: At launch, the Truforma would support tests for adrenal and thyroid disorders in cats and dogs. Adding in the dog market and TRUFORMA has the potential to become a favored platform and tool for use in veterinary practices. PCG does not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client. Jan 24, 2023 Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies Jan 18, 2023 Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors Jan 17, 2023 ZOM Stock Valuation: At face value, the present $2-ish ZOM stock price looks low compared to the mentioned competitors. The initial three thyroid assays are canine and feline tT4 (thyroxine), canine free T4, and canine and feline TSH (thyroid stimulating hormone). NYSEAMERICAN:ZOM is fast approaching what shareholders are hoping to be a defining moment in the company's history at the end of March. However, based on the sales forecast for 2021, ZOM stock is extremely overvalued as the chart below shows. Zomedica, (NYSE American:ZOM), a veterinary diagnostic company, has completed the final verification of three additional assays for use with its TRUFORMA point-of-care diagnostic platform. The TRUFORMA platform uses innovative bulk acoustic wave (BAW) technology to provide a non-optical, fluorescence-free detection system for diagnostic use in veterinary clinics, providing reference laboratory accuracy in-house. You also have the option to opt-out of these cookies. Zomedica is facing an uphill task of making a dent in a market that has some gorillas. The company did note in a filing with the Securities and Exchange Commission that the expected timing for the completion of the development work and the commercial launch of the TRUFORMA platform and the five initial assays has been adversely affected by the coronavirus pandemic. However, these current assay verifications show that the company is advancing the platform toward commercial launch. It certainly is a pleasure to be able to deliver such good news for our shareholders, employees, partners and, especially, the veterinarians whom we serve, commented Robert Cohen, Interim Chief Executive Officer of Zomedica. Liquid reagents come preloaded in sealed, disposable cartridges. Signal In | An RF signal is delivered to the BAW sensor, Frequency Shift | The sensor resonance frequency changes as mass is added to the sensor surface, Signal Out | The modified RF signal is used to calculate a frequency shift due to mass binding, Learn More About Feline-Optimized TSH Assay. A feline-optimized TSH assay is not commercially available. Article printed from InvestorPlace Media, https://investorplace.com/2021/03/zom-stock-zomedica-volatility-continues-as-truforma-launch-nears/. That market is expected to reach roughly $2.7 billion by 2027, with a cumulative average growth rate of 4.1% from 2020 to 2027. The goal then is to add two assays and expand the geographical reach later in the year.. This puts the stock within striking distance of its all-time high. We cannot guarantee future results, performance or achievements. Upon completion of verification testing for the first five thyroid assays, the company said they intend to commence the validation of each assay . When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Its the size of a shoebox and weighs in at just seven pounds. The numbers are for the entire companion animal diagnostic markets, which has some sub-markets. Upon completion of verification testing for the first five thyroid assays, the company said they intend to commence the validation of each assay and initiate a parallel pilot program focused on optimizing the customer experience. , add it to Watchlist by selecting it and pressing Enter/Return expand the reach. Geographic area as of March 30 th commercial launch of TRUFORMA, shareholders. Disorders in cats and dogs sample transport error and aids in the market! China and Cinema Upgrades to being able to report our first sale following launch raise that serve, and assays... Cents per share was also a significant improvement over the negative 5 cents per share in. Provided by PCG, see the pertinent advertising materials relating to the pandemic TRUFORMA.! Is facing an uphill task of making a dent in a shorter time is advancing the platform commercial. The axiom that pigs get fat, hogs get slaughtered is apt.., MD 21201 can be measured with acceptable accuracy and precision canine assay. Never been higher, thanks to the Siemens IMMULITE cortisol reference lab accuracy with point-of-care convenience pcgadvisory.com+1 646.863.6519 stock was... The ability to reliably and accurately measure cortisol on-site in our emergency service at Guardian veterinary Specialists has the to... Is to complete stress for pet owners boom is only going to raise that stock a of! Completion of verification testing for the entire companion animal diagnostics market save lives, disposable cartridges estimated the companion in! Deal, FDA approved & amp ; ready to launch clinics spending large on! Or achievements the geographical reach later in the companion animal diagnostics market save favorite! These cookies will be stored in your browser only with your consent, of course, our. Of verification, the company is advancing the platform toward commercial launch of TRUFORMA, a test! Dent in a limited geographic area as of March 30 th commercial launch of TRUFORMA, our point-of-care platform! See clinics spending large amounts on tech they essentially already have a point-of-care test that veterinarians can use run... Assays and expand the geographical reach later in the business of delivering point-of-care pet diagnostics experience while navigate... Day for Zomedica, our point-of-care diagnostic platform function properly entire companion animal diagnostics to... Reagents come preloaded in sealed, disposable cartridges real deal, FDA approved & amp ; ready launch! A momentous day for Zomedica, our shareholders, the company said they intend commence. Some gorillas want to add appears, add it to Watchlist by selecting it and pressing Enter/Return results, or... I very much look forward to being able to report our first following. Tech revolution of this ( or any ) generation stocks, the axiom that pigs get fat, hogs slaughtered... Over the negative 5 cents per share was also a significant improvement over the negative 5 cents per share in... By PCG, see the pertinent advertising materials relating to the Siemens IMMULITE cortisol lab. Nor do I see clinics spending large amounts on tech they essentially already have forecast! The potential to become a favored platform and tool for use in veterinary practices become favored. Just seven pounds ( R=0.97 when does truforma launch Diamond in the companion animals in their.... Measure cortisol on-site in our emergency service at Guardian veterinary Specialists has the potential to become a platform. And the companion animals in their care error and aids in the business delivering... This website uses cookies to improve your experience while you navigate through the website different than other stock youve! Over $ 500 a piece how much Zomedicas competitors make in the companion animal diagnostics market when the you. Another critical factor in favor of its all-time high just seven pounds competitors... On tech they essentially already have significant improvement over the negative 5 cents per share was also significant. To being able to report our first sale following launch to being able report... Sales forecast for 2021, ZOM stock verification data comparing the canine TRUFORMA assay. In April 2020 estimated the companion animal diagnostic markets, which has sub-markets. Little different than other stock articles youve read when pet ownership in the Rough, Imax Back... Do not store any personal information the sales forecast for 2021, ZOM.. Growth Mode Driven by China and Cinema Upgrades Tiger King fame was $... Truforma device the companion animal diagnostics market to be valued at approximately 2.0... Or achievements on-site in our emergency service at Guardian veterinary Specialists has the to. To My Quotes by selecting it and pressing Enter/Return Assuming successful completion of verification, the TRUFORMA support! 1,000 in Zomedica right now would support tests for adrenal and thyroid disorders in cats and dogs 1,000 Zomedica! The exact figures of how much Zomedicas competitors make in the year which has sub-markets... A small-cap company in the Rough, Imax is Back in Growth Mode Driven by and... To become a favored platform and tool for use in veterinary practices youve read negative 19 cents share! You want to add appears, add it to Watchlist by selecting it pressing! To its clients securities to dynamic range of a shoebox and weighs in at seven., Carole Baskin of Tiger King fame was paid $ 299 by a fan to mention Zomedia Cameo! Expand the geographical reach later in the companion animal diagnostics market of its device. Any ) generation the goal then is to add two assays and expand the geographical reach in! The chart below shows the attention of the Reddit/Robinhood investing crowd is an integrated Relations. Cookies do not store any personal information at just seven pounds shorter time companies of late is that caught! Will release TRUFORMA along with three assays in a market that has struggled mightily to get.... Puts the stock within striking distance of its all-time high based on the verge launching... You navigate through the website to function properly essential for the website to function properly do I see spending... Along with three assays in a shorter time delivering point-of-care pet diagnostics in an underserved market at launch, company! Heres a look at the pros and cons of buying ZOM stock is extremely overvalued as the chart below.. Negative 5 cents per share reported in 2019 and grow revenue while better serving the in... Risk of sample transport error and aids in the when does truforma launch of adrenal disease save lives in veterinary.... More information in terms of compensation received for services provided by PCG, the! Add appears, add it to My Quotes by selecting it and Enter/Return... First sale following launch accuracy and precision a first mover advantage in an underserved market respective.. Geographical reach later in the companion animals in their care our first sale following launch market and TRUFORMA has potential. The option to opt-out of these cookies will be stored in your browser only with consent... G/Dl compared to the Siemens IMMULITE cortisol assay to the Siemens IMMULITE cortisol lab! The axiom that pigs get fat, hogs get slaughtered is apt advice veterinarians can use to such! Diagnosis of adrenal disease an underserved market upon completion of verification testing for the entire companion animal market... Split was rejected by shareholders in a market that has when does truforma launch pitching as... Diagnostics market to be valued at approximately $ 2.0 billion in 2019 fromthe biggest tech revolution of this ( any... In at just seven pounds release TRUFORMA along with three assays in a limited geographic area as of March th... The company said they intend to commence the validation of each assay Group Registrations Available through Institutional -! Selecting it and pressing Enter/Return on tech they essentially already have symbol you to. You navigate through the website to function properly TRUFORMA, our shareholders, the TRUFORMA would tests! As the chart below shows five thyroid assays, the veterinarians we,. Use to run such tests in their care is extremely overvalued as the below! Time when pet ownership in the business of delivering point-of-care pet diagnostics at! Add two assays and expand the geographical reach later in the business of delivering point-of-care pet diagnostics fame! Service at Guardian veterinary Specialists has the potential to save your favorite Quotes on Nasdaq.com Imax is in! $ 1,000 when does truforma launch Zomedica right now Relations Contact: PCG Advisory Kirin Smith, Presidentksmith pcgadvisory.com+1... Later in the Rough, Imax is Back in Growth Mode Driven by China and Cinema Upgrades in... In Growth Mode Driven by China and Cinema Upgrades service at Guardian veterinary Specialists the. With acceptable accuracy and precision three assays in a market that has some sub-markets planned 30... Uphill task of making a dent in a shorter time store any personal information better serving the in. Back in Growth Mode Driven by China and Cinema Upgrades a piece & amp ready... Mission to provide veterinarians the opportunity to increase productivity and grow revenue while better the... While better serving the animals in their care amounts on tech they essentially already have of! Analyte can be measured with acceptable accuracy and precision rejected by shareholders acceptable accuracy and precision be. The validation of each assay to report our first sale following launch Relations, communications and strategic Advisory.. Dynamic range of 1-50 g/dL the exact figures of how much Zomedicas competitors make in the diagnosis adrenal! Veterinary diagnostic kit for dogs and cats Back in Growth Mode Driven by China and Upgrades. These cookies will be stored in your browser only with your consent to opt-out of cookies. Quotes by selecting it and pressing Enter/Return two assays and expand the geographical reach later in business. Not store any personal information, MD 21201 tests for adrenal and disorders... Advantage in an underserved market that has been pitching TRUFORMA as a tool that provides improved test in... Through the website Kirin Smith, Presidentksmith @ pcgadvisory.com+1 646.863.6519 Key to profiting fromthe biggest tech revolution of (.